ArticleThe European respiratory journal2023
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.
Open access · hybridAbstract readLetter
In one paragraph
Article in The European respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 19 citations in OpenAlex.
- Interest of ventilation/perfusion SPECT/CT in patients with post-COVID condition: a multicenter observational study.European journal of nuclear medicine and molecular imaging · 2025Observational
- Chronic Dyspnea and Residual Pulmonary Vascular Sequelae After COVID-19 Pulmonary Embolism: A Retrospective Analysis.Pulmonary circulation · 2025Article
- Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.ERJ open research · 2025Article
- The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization.Research and practice in thrombosis and haemostasis · 2024Article
- Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.The European respiratory journal · 2024Observational
- Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.International journal of molecular sciences · 2024Article
- Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.International journal of molecular sciences · 2024Review
- Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study.Scientific reports · 2024Article
- Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 14 institutions in 1 country.
Cindy M M de JongDepartment of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-2310-5820
Chantal VisserDepartment of Haematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-2025-1734
Remy H H BemelmansDepartment of Internal Medicine, Hospital Gelderse Vallei, Ede, The Netherlands.
Wim G BoersmaDepartment of Pulmonology, North West Hospital Alkmaar, Alkmaar, The Netherlands.
Bram van den BorstDepartment of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-4597-2722
J Louise I BurggraafDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Suzanne C CannegieterDepartment of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-4707-2303
Arina J Ten Cate-HoekThrombosis Expertise Center Maastricht and Department of Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
F Nanne CrolesDepartment of Internal Medicine, Hospital St. Jansdal, Harderwijk, The Netherlands.
Harald J FaberDepartment of Intensive Care, Wilhelmina Hospital Assen, Assen, The Netherlands.
Laura M FaberDepartment of Internal Medicine, Rode Kruis Hospital, Beverwijk, The Netherlands.
Merel E HellemonsDepartment of Respiratory Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-6666-5027
Lisa M HesselsDepartment of Pulmonology, North West Hospital Alkmaar, Alkmaar, The Netherlands.ORCID 0000-0002-0564-1064
Menno V HuismanDepartment of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-1423-5348
Pieter W KamphuisenDepartment of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands.
Stephanie C E KosterDepartment of Intensive Care, Zaans Medical Centre, Zaandam, The Netherlands.ORCID 0000-0001-6667-6714
Lucia J M KroftDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-4734-8616
Ivo van der LeeDepartment of Pulmonology, Spaarne Hospital, Haarlem, The Netherlands.
Jenneke LeentjensDepartment of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-3356-3910
Karina MeijerDepartment of Haematology, University Medical Centre Groningen, Groningen, The Netherlands.
Maarten K NinaberDepartment of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Brigitte M SondermeijerDepartment of Pulmonology, Spaarne Hospital, Haarlem, The Netherlands.
Susanne StadsDepartment of Intensive Care, Ikazia Hospital, Rotterdam, The Netherlands.
Anton Vonk NoordegraafDepartment of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-4057-758X
Kristien WinckersThrombosis Expertise Center Maastricht and Department of Internal Medicine, Section Vascular Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Marieke J H A KruipDepartment of Haematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-0265-4871
Frederikus A KlokDepartment of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands f.a.klok@lumc.nl.ORCID 0000-0001-9961-0754
Dutch COVID & Thrombosis Coalition investigators
Leiden University Medical Center · NLErasmus MC · NLMaastricht University · NLMedisch Centrum Alkmaar · NLRadboud University Nijmegen · NLSpaarne Ziekenhuis · NLAmsterdam University Medical Centers · NLIkazia Ziekenhuis · NLRijnstate Hospital · NLRode Kruis Ziekenhuis · NLTergooi · NLUniversity Medical Center Groningen · NLZaans Medisch Centrum · NLZiekenhuis Gelderse Vallei · NL
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Hypertension, PulmonaryPulmonary EmbolismThrombosisChronic DiseaseHumans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.